CompletedNot Applicable

ESP vs Retrolaminar Block: A Randomized Trial

Pakistan90 participantsStarted 2022-02-01

Plain-language summary

The study aims to compare the efficacy in pain control and total opioid consumption after the use of ESPB and retrolaminar block in patients undergoing major oncological breast surgery..

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patients between 18- 60 years ASA 1 and 2 Exclusion Criteria: * Patient refusal Allergic reaction infection emergency case BMI \>35

What they're measuring

Comparison of pain score of patients receiving ESPB and retrolaminar block

Timeframe: 2hours post surgery

Trial details

NCT IDNCT07200960

SponsorShaukat Khanum Memorial Cancer Hospital & Research Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Pain Management trials